Publications database

This poster, presented during the IX International Conference on NPS (24 to 26 Oct 2022, Panama), showcases some of the work of the EU Early Warning System on new psychoactive substances. Operated by the EMCDDA, in close cooperation with Europol and other partners, it was the first regional early-...

The European Web Survey on Drugs collected data during March and May 2021 from people who use drugs, are aged 18 or older, and live in 21 EU and 9 non-EU countries including Lebanon. In this period, the populations in many European and neighbouring countries were experiencing COVID-19-related...

The European Web Survey on Drugs collected data during March to May 2021 from people who use drugs, are aged 18 or older and live in Georgia. In this period, the populations in many European and neighbouring countries were experiencing COVID-19-related lockdown or restrictions. Unless otherwise...

The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions.

Risk assessment is the second step in the three-step legal framework designed to allow the European Union (EU) to rapidly detect, assess, and respond to health and social threats caused by new psychoactive substances (NPS). On this page you can learn the role of the risk assessment in the EU earl...

This publication presents the data and findings of the risk assessment on 2-(methylamino)-1-(3-methylphenyl)propan-1-one (3-methylmethcathinone, 3-MMC), carried out by the extended Scientific Committee of the EMCDDA on 18 November 2021. On the basis of the Risk Assessment Report, on 18 March 2022,...

The European Web Survey on Drugs collected data between March and April 2021 from people who use drugs, aged 18 or older, living in 21 EU and 9 non-EU countries. This fact sheet presents some of the top-level findings from five countries in the Western Balkans.

3-CMC is a synthetic cathinone monitored by the EMCDDA as a new psychoactive substance through the European Union Early Warning System since 2014. Based on potential public health risks, an initial report has been prepared and submitted to the Commission and the Member States, in accordance with...

New opioids are synthetic narcotic analgesics that have recently appeared on the drugs market, many of which are highly potent substances that pose a life-threatening risk of poisoning. Fentanils are a particularly potent group of synthetic opioids, which in some cases are used in human and...